Rapid testing for coronavirus disease 2019 (COVID-19)

Rapid testing, generally refers to the paper-based diagnostic platform known as “lateral flow assay” (LFA), has emerged as a critical asset to the containment of coronavirus disease 2019 (COVID-19) around the world. LFA technology stands out amongst peer platforms due to its cost-effective design, u...

Descripción completa

Detalles Bibliográficos
Autores principales: Biby, Alexander, Wang, Xiaochuan, Liu, Xinliang, Roberson, Olivia, Henry, Allya, Xia, Xiaohu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Prospective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769796/
https://www.ncbi.nlm.nih.gov/pubmed/35075405
http://dx.doi.org/10.1557/s43579-021-00146-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769796/
https://www.ncbi.nlm.nih.gov/pubmed/35075405
http://dx.doi.org/10.1557/s43579-021-00146-5

Ejemplares similares